RTI Surgical (NASDAQ:RTIX) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday.

Several other research analysts have also issued reports on RTIX. Zacks Investment Research upgraded RTI Surgical from a “hold” rating to a “buy” rating and set a $5.25 price target on the stock in a research report on Tuesday, August 7th. ValuEngine lowered RTI Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, November 27th.

Shares of RTIX opened at $3.95 on Tuesday. The firm has a market capitalization of $264.64 million, a price-to-earnings ratio of 79.00 and a beta of 1.39. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.35 and a current ratio of 3.59. RTI Surgical has a 52 week low of $3.90 and a 52 week high of $5.10.

RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings data on Thursday, November 1st. The medical equipment provider reported $0.03 EPS for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.02. The firm had revenue of $69.06 million for the quarter, compared to analyst estimates of $70.09 million. RTI Surgical had a positive return on equity of 4.04% and a negative net margin of 3.91%. Analysts forecast that RTI Surgical will post 0.11 EPS for the current year.

Several large investors have recently bought and sold shares of RTIX. Vanguard Group Inc. boosted its position in shares of RTI Surgical by 15.0% in the 3rd quarter. Vanguard Group Inc. now owns 2,883,306 shares of the medical equipment provider’s stock worth $12,975,000 after purchasing an additional 375,027 shares during the last quarter. BlackRock Inc. raised its stake in RTI Surgical by 5.7% during the 2nd quarter. BlackRock Inc. now owns 4,947,475 shares of the medical equipment provider’s stock worth $22,758,000 after buying an additional 267,654 shares during the period. Rutabaga Capital Management LLC MA raised its stake in RTI Surgical by 22.4% during the 2nd quarter. Rutabaga Capital Management LLC MA now owns 1,375,290 shares of the medical equipment provider’s stock worth $6,326,000 after buying an additional 251,894 shares during the period. Russell Investments Group Ltd. raised its stake in RTI Surgical by 299.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 307,067 shares of the medical equipment provider’s stock worth $1,383,000 after buying an additional 230,103 shares during the period. Finally, Royce & Associates LP raised its stake in RTI Surgical by 22.6% during the 3rd quarter. Royce & Associates LP now owns 1,039,706 shares of the medical equipment provider’s stock worth $4,679,000 after buying an additional 191,335 shares during the period. Institutional investors and hedge funds own 70.10% of the company’s stock.

About RTI Surgical

RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

See Also: What is the LIBOR?

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.